Fleishman S B, Lavin M R, Sattler M, Szarka H
Department of Medicine and Psychiatry, Long Island Jewish Medical Center, New Hyde Park, NY 11042.
Am J Psychiatry. 1994 May;151(5):763-5. doi: 10.1176/ajp.151.5.763.
A structured, prospective telephone interview was used to assess the prevalence of akathisia in 24 cancer patients receiving metoclopramide or prochlorperazine during or after chemotherapy. Half of the patients reported subjective motor restlessness, and 75% stated that they would not have informed staff. This report suggests that akathisia is frequently unrecognized in chemotherapy patients receiving metoclopramide and prochlorperazine.
采用结构化的前瞻性电话访谈，评估24例在化疗期间或化疗后接受甲氧氯普胺或氯丙嗪的癌症患者中静坐不能的患病率。一半的患者报告有主观的运动性不安，75%的患者表示他们不会告知医护人员。本报告表明，在接受甲氧氯普胺和氯丙嗪的化疗患者中，静坐不能常常未被识别。
